Cargando…
Identification of clinical phenotypes in schizophrenia: the role of lurasidone
The treatment of schizophrenia includes the control of symptoms, the prevention of relapses, and amelioration of adaptive skills for patient re-integration into society. Antipsychotic drugs are the agents of choice for the treatment of schizophrenia, as they reduce the positive symptoms of psychosis...
Autores principales: | Riva, Marco Andrea, Albert, Umberto, de Filippis, Sergio, Vita, Antonio, De Berardis, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120523/ https://www.ncbi.nlm.nih.gov/pubmed/34025981 http://dx.doi.org/10.1177/20451253211012250 |
Ejemplares similares
-
The role of duloxetine in the treatment of anxiety disorders
por: De Berardis, Domenico, et al.
Publicado: (2008) -
The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia
por: Pietrini, Francesco, et al.
Publicado: (2019) -
Emerging role of sertindole in the management of schizophrenia
por: Cincotta, Stephanie L, et al.
Publicado: (2010) -
Use of cluster analysis to describe desaturator phenotypes in COPD: correlations between pulmonary function tests and nocturnal oxygen desaturation
por: Toraldo, Domenico Maurizio, et al.
Publicado: (2011) -
Quetiapine in the treatment of schizophrenia and related disorders
por: Riedel, Michael, et al.
Publicado: (2007)